Skip to main content

Change in PDL Status for Intranasal Rhinitis Agents Drug Class Effective September 29, 2025

Last updated on

On September 29, 2025, the Texas Health and Human Services Commission (HHSC) removed the non-preferred status from certain generic azelastine and fluticasone nasal products on the preferred drug list (PDL) because of product shortages.

The non-preferred status has been removed from the following drugs:

National Drug Code (NDC)Drug Name
45802006601Azelastine/fluticasone 137 mcg-50 mcg spr
60505095303Azelastine/fluticasone 137 mcg-50 mcg spr

Contact Information

Email vdp-formulary@hhsc.state.tx.us with comments or any questions.